Maintenance immunosuppression.

An "intent-to-treat" analysis was developed to examine the administration of primary and adjunctive immunosuppressive agents by year of transplant for unsensitized, sensitized, multi-organ and living donor transplant recipients by centers reporting to the UNOS Registry of Renal Transplant Recipients. Based on these analyses, several trends were noted… CONTINUE READING